Overview

Detailed Summary

Deep Diamond India Limited is primarily engaged in the business of rough and polished diamonds, as well as the sale and trading of diamond-studded and gold jewelry.
The company has diversified its business portfolio by entering the consultancy services sector for the pharmaceutical industry starting from the financial year 2022-23.
The diamond and jewelry business remains the core aspect of Deep Diamond India Limited's operations, reflecting its long-standing presence in the sector since 1994.
While known for its expertise in the gem and jewelry industry, the company's recent diversification into pharmaceutical consultancy marks a strategic business shift.

Sector: Consumer Durables
Industry: Gems, Jewellery And Watches
Market Cap: 26 Cr
Volatility: Low Risk
P/E Ratio: 4.4
Industry P/E: 46.7
PEG Ratio: 0.1
P/B Ratio: 0.7
52W High: 10.29
52W Low: 1.65

Sales CAGR

1Y: -50.78%
3Y: -3.30%
5Y: 9.21%
10Y: 0.79%

Profit CAGR

1Y: 109.52%
3Y: 63.46%
5Y: —
10Y: —

ROE

TTM: 11.62%
3Y: 4.41%
5Y: 3.70%
10Y: 2.37%

ROCE

TTM: 15.29%
3Y: 6.77%
5Y: 5.73%
10Y: 3.71%

Technicals

‌

Forecasts

Peers

Consumer Discretionary Consumer Durables Consumer Durables Gems, Jewellery And Watches

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
KANANIIND		1.28	28 Cr	14.22	0.41	0.00	3.15	3.37	1.87
TRITON		1.34	27 Cr	26.80	42.26	0.00	95.66	21.52	21.16
GOENKA		0.84	27 Cr	-28.00	0.11	0.00	-0.70	-0.26	-0.13
SHUBHLAXMI		25.00	27 Cr	29.41	1.17	0.00	10.34	12.87	5.27
DDIL		1.80	26 Cr	4.35	0.73	0.00	11.62	15.29	21.04
DARSHANORNA		2.52	26 Cr	42.00	0.74	0.00	2.95	3.29	2.23
KENVI		1.92	26 Cr	10.11	1.62	0.00	6.23	8.14	4.44
Median: 7 Co.	—	1.80	27 Cr	14.22	0.74	0.00	6.23	8.14	4.44

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	0.89	0.86	1.70	0.51	0.30	0.00	0.45	0.15	3.35	0.50
Expenses	1.47	0.76	2.03	0.29	0.17	0.15	0.22	0.20	0.12	0.40
Operating Profit	-0.58	0.10	-0.33	0.22	0.13	-0.15	0.23	-0.05	3.23	0.10
OPM %	-65.17	11.63	-19.41	43.14	43.33	—	51.11	-33.33	96.42	20.00
Other Income	0.26	0.55	0.52	0.19	0.09	0.22	0.25	0.16	0.16	3.56
Interest	0.03	0.05	0.21	0.03	0.02	0.01	0.03	0.01	0.01	0.01
Depreciation	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	-0.35	0.58	-0.03	0.38	0.20	0.06	0.45	0.10	3.38	3.66
Tax %	0.00	10.34	-333.33	26.32	25.00	83.33	8.89	30.00	25.15	16.67
Net Profit	-0.35	0.52	-0.13	0.29	0.15	0.01	0.41	0.06	2.53	3.04
EPS in Rs	-0.24	0.37	-0.09	0.03	0.03	-0.02	0.02	0.00	0.18	0.21

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024	TTM
Sales	2.56	0.90
Expenses	2.80	0.74
Operating Profit	-0.25	0.16
OPM %	-9.67	17.78
Other Income	1.07	0.72
Interest	0.26	0.07
Depreciation	0.01	0.00
Profit Before Tax	0.56	0.81
Tax %	25.15	22.22
Net Profit	0.42	0.63
EPS in Rs	0.05	0.41
Dividend Payout %	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024
Equity Capital	4.81
Reserves	16
Borrowings	1.66
Other Liabilities	0.98
Total Liabilities	23
Fixed Assets	0.03
CWIP	0.00
Investments	7.97
Other Assets	15
Total Assets	23

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024	Mar 2025
Cash from Operating Activity	-5.43	0.19
Cash from Investing Activity	-2.23	-0.23
Cash from Financing Activity	5.01	0.00
Net Cash Flow	-2.65	-0.04

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Oct 2025	Dec 2025
Promoters	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.03%	0.03%
FIIs	1.04%	1.04%	1.04%	1.04%	1.04%	1.04%	1.04%	1.04%	1.04%	1.04%	0.35%	0.35%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	98.88%	98.88%	98.88%	98.88%	98.88%	98.88%	98.87%	98.87%	98.87%	98.87%	99.62%	99.62%
Total Shareholders	29,349	29,044	28,157	27,514	26,508	63,032	66,386	63,304	62,527	60,444	61,426	77,632

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Director Resignation

3 days ago

Independent Director Resignation

Mr. Kailash Chandra (DIN: 10985611) has resigned as Independent Director of Deep Health AI India Limited effective at close of business on April 03, 2026.

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Deep Health AI India Ltd

Deep Health AI India Ltd (DDIL) is currently trading at 1.89 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Deep Diamond India Limited is primarily engaged in the business of rough and polished diamonds, as well as the sale and trading of diamond-studded and gold jewelry. The company has diversified its business portfolio by entering the consultancy services sector for the pharmaceutical industry starting from the financial year 2022-23. The diamond and jewelry business remains the core aspect of Deep Diamond India Limited's operations, reflecting its long-standing presence in the sector since 1994. While known for its expertise in the gem and jewelry industry, the company's recent diversification into pharmaceutical consultancy marks a strategic business shift.

Over the past 52 weeks, Deep Health AI India Ltd has traded between a low of ₹1.65 and a high of ₹10.29. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Deep Health AI India Ltd has a market capitalization of approximately 25.95. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Deep Health AI India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 4.35 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 25.95 Cr, Deep Health AI India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Deep Health AI India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Deep Health AI India Ltd is 4.35. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Deep Health Ai India Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison